Development of a potent respiratory syncytial virus-specific monoclonal antibody for the prevention of serious lower respiratory tract disease in infants
No abstract is available. To read the body of this article, please view the PDF online.
aResearch and Development, MedImmune Inc. Gaithersburg, MD, U.S.A.
f1 Correspondence should be addressed to: James Young, PhD, MedImmune, Inc., 35 W. Watkins Mill Road, Gaithersburg, MD 20878, U.S.A. Fax: +1 301 527 4203 E-mail: YoungJ@MedImmune.Com
